(Q34760384)

English

Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

author name string

Michael J Schwartz

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

David H Hwang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Andrew J Hung

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Jullet Han

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Justin W McClain

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

M Mendel Shemtov

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Alexis E Te

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

R Ernest Sosa

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

E Darracott Vaughan

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Douglas S Scherr

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1718-1725

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

21 January 2018

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive and negative biopsies in the pre-prostate specific antigen and prostate specific antigen eras, 1980 to 1997.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

The independent impact of extended pattern biopsy on prostate cancer stage migration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer and the Will Rogers phenomenon.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Age and racial distribution of prostatic intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

An abnormal digital rectal examination is an independent predictor of Gleason > or =7 prostate cancer in men undergoing initial prostate biopsy: a prospective study of 790 men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive prostate biopsy rate consistently increases with age at the same prostate-specific antigen level in patients with normal digital rectal examination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23353

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23353

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34760384&oldid=1634753932"